Potential tools include using primary care blood tests (albumin, alkaline phosphatase, C-reactive protein, hemoglobin, liver enzymes, platelets, and total white cell count) in patients with nonspecific signs and/or symptoms [22] or using prediction algorithms to identify which patients may require further investigation for cancer [23,24]. The gene discussed is ALB; the disease is cancer.